- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01670123
Development of a Personalized Real-time Intervention for Bipolar Disorder (PRISM)
October 9, 2018 updated by: Colin Depp, University of California, San Diego
This three-year intervention development proposal is submitted to the NIMH DATR Mood Disorders/Sleep Disorders Program A2-AID and is led by a New Investigator.
The goal of this study is to further develop and then evaluate the clinical utility of a new personalized smart-phone intervention to enhance illness self-management in people with bipolar disorder.
Bipolar disorder is a heterogeneous fluctuating condition and a leading source of disability.
Consistent with NIMH Strategic Aim 3.2, self-monitoring tools are vital to clinical management and evidence-based psychosocial interventions for bipolar disorder.
Practice guidelines state that all patients should receive education in self-monitoring and identifying adaptive responses to early warning signs and symptoms.
Advances in technology have enabled electronic monitoring of patient-reported outcomes using mobile devices - an assessment strategy called Ecological Momentary Assessment (EMA).
Using freely available software, we have developed a preliminary version of a novel smart-phone intervention that integrates EMA with brief psychosocial intervention designed for people with bipolar disorder.
Mobile real-time interventions have been successfully applied in other chronic illnesses and have theoretical advantages over clinic-based interventions in motivating and cuing health-protective behavior.
Our new intervention is called Personalized Real-Time Intervention for Stabilizing Mood (PRISM), and it delivers tailored intervention content naturalistically at the moment that symptoms occur.
We recently conducted a small proof-of-concept study of PRISM in outpatient adults with bipolar disorder that suggests the intervention is feasible, presents no technological or operational barriers, yields data that corresponds with clinical ratings, and is perceived as useful by participants.
Building from our preliminary work, we propose to further develop the intervention based on participant feedback and theoretically-driven enhancements.
We will then conduct a randomized trial to assess the clinical utility of this new intervention over 12 weeks.
Specifically, we will randomize a sample of 90 adults aged 18 and older with Bipolar Disorder I or II to one of two experimental conditions.
Participants in both conditions will participate in two in-person sessions adapted from an evidence-based psychosocial intervention for bipolar disorder, aimed at identifying early warning signs and adaptive responses to symptom fluctuations.
The Control condition will participate in the in-person sessions, and the PRISM condition will also utilize the smart phone device for 12 weeks.
In this pilot trial, we will compare outcomes between the two conditions on standard clinical ratings of depressive and manic symptoms, along with psychosocial functioning.
We will assess predictors of compliance and changes in outcomes in the PRISM condition to inform a larger effectiveness trial.
We will use exploratory analyses to further refine the intervention, including capitalizing on the rich repeated measures obtained by the device.
This study will provide a strong basis for a larger effectiveness trial, along with a potentially useful tool to enhance self-management in bipolar disorder.
PUBLIC HEALTH RELEVANCE: Bipolar disorder is a leading cause of disability, and many people do not have access to evidence-based psychosocial interventions.
Mobile devices may prove more effective than clinic-based interventions, because they deliver self-management strategies at the moment that symptoms occur.
To lead to a larger effectiveness study, we propose to further develop our novel intervention uses mobile technology to monitor and intervene with symptoms in real-time, and then conduct a 12-week randomized trial in 90 patients to evaluate the acceptability and short-term efficacy of our smart-phone based intervention for bipolar disorder.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
La Jolla, California, United States, 92037
- University of California, San Diego
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- DSM-IV diagnosis of bipolar disorder
- Currently an outpatient
Exclusion Criteria:
- Psychiatric hospitalization in the past month
- Substance abuse diagnosis in the past 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mobile Phone Condition
This arm will involve daily self-monitoring with an electronic mobile device with responses to survey questions about mood status.
Mood status reports are linked with personalized coping strategies.
|
Interactive mobile web-based behavioral intervention targeting symptoms of bipolar disorder
|
|
Placebo Comparator: Paper-and-pencil condition
This arm will complete a paper-and-pencil mood chart on a daily basis
|
Interactive mobile web-based behavioral intervention targeting symptoms of bipolar disorder
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Montgomery Asberg Depression Rating Scale
Time Frame: 3 month
|
Depression severity measure
|
3 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Young Mania Rating Scale
Time Frame: 3 Month
|
Mania symptom severity
|
3 Month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2010
Primary Completion (Actual)
June 1, 2013
Study Completion (Actual)
June 1, 2013
Study Registration Dates
First Submitted
August 17, 2012
First Submitted That Met QC Criteria
August 20, 2012
First Posted (Estimate)
August 21, 2012
Study Record Updates
Last Update Posted (Actual)
October 11, 2018
Last Update Submitted That Met QC Criteria
October 9, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MH091260
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bipolar Disorder
-
Vielight Inc.Not yet recruitingBipolar Disorder (BD) | Bipolar | Bipolar Disorder DepressionCanada
-
ProgenaBiomeWithdrawnBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
University of Texas Southwestern Medical CenterThe Texas Child Mental Health Care Consortium (TCMHCC)RecruitingBipolar Disorder Family Members | Bipolar Disorder (BD) | Bipolar Disorder I or II | Screening ToolUnited States
-
Xenon Pharmaceuticals Inc.RecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderUnited States
-
Xenon Pharmaceuticals Inc.Enrolling by invitationBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderUnited States
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationCompletedBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar Disorder I | Bipolar Affective DisorderUnited States
-
University of California, Los AngelesUniversity of Colorado, Denver; University of Pittsburgh; University of Cincinnati and other collaboratorsRecruitingAdolescents | Bipolar Disorder (BD) | Bipolar Disorder I or II | Bipolar Disorder NOS | Bipolar Spectrum DisorderUnited States
-
Babes-Bolyai UniversityRecruitingBipolar Disorder (BD)Romania
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Hospital Moinhos de VentoActive, not recruitingBipolar Disorder | Bipolar Depression | Major Depressive Disorder | Bipolar I Disorder | Affective Disorder | Bipolar II DisorderBrazil
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionCompletedBipolar I Disorder | Bipolar II Disorder | Bipolar Disorder NOSUnited States
Clinical Trials on Personalized Real-Time Intervention for Stabilizing Mood
-
Hasselt UniversityUniversity Hospital, AntwerpActive, not recruiting
-
Federal University of Health Science of Porto AlegreCompletedFall | Elderly | Physical Therapy | Prevention | TelehealthBrazil
-
San Diego State UniversityCompletedLung Diseases | AsthmaUnited States
-
Yale UniversityPatterson Trust Mentored Research Award: Clinical, Health Services and Policy...CompletedTobacco Use CessationUnited States
-
Mayo ClinicCompletedEvaluate the Role of Real-time Imaging in Needle Placement | Evaluate the Workflow and Effectiveness of Realtime Imaging Versus Standard MR ImagingUnited States
-
University of MinnesotaNational Institute of Mental Health (NIMH)Active, not recruitingSchizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Schizoaffective Disorder | Bipolar Disorder | Psychosis | Schizo Affective Disorder | Prodromal Schizophrenia | Major Depression With Psychotic Features | Schizophreniform Disorders | Unspecified Psychosis | Psychosis Nos/OtherUnited States
-
Taipei Medical UniversityRecruitingType 2 Diabetes | M-health | AI-supported Real-time Dietary FeedbackTaiwan
-
Pakistan Institute of Living and LearningCompleted
-
University of North Carolina, Chapel HillUniversity of South Carolina; East Carolina UniversityCompletedNon-small Cell Lung CancerUnited States
-
University of VirginiaCarilion Clinic; North Carolina Agriculture & Technical State UniversityUnknownDementia | Caregivers | Behavioral and Psychiatric Symptoms of DementiaUnited States